Restatement Of Condensed Consolidated Financial Statements (Condensed Consolidated Statements Of Cash Flow) (Detail) (USD $) In Thousands, unless otherwise specified	9 Months Ended			12 Months Ended
	Sep. 30, 2011		Sep. 30, 2010	Dec. 31, 2010
Cash flows from operating activities of continuing operations
Net loss	$ (854,102)	[1]	$ (1,464)	$ (138,073)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization	15,328	[1]	12,717
Deferred income taxes	(5,138)	[1]	(12,103)
Unrealized foreign exchange (gains) / losses	118,366	[1]	(2,090)
Stock options fair value expense	1,998	[1]	2,433
Equity (income)/loss in affiliates	7,946	[1]	(2,163)
Gain on fair value remeasurement of previously held equity interest	(6,397)	[1]	0
Impairment charge	674,515	[1]	0
Impairments related to assets held for sale	7,355	[1]	0
Other non-cash items	6,170	[1]	11,532
Changes in operating assets and liabilities:
Accounts receivable	246,153	[1]	155,430
Inventories	(9,183)	[1]	(3,179)
Prepayments and other current assets	(7,701)	[1]	(4,253)
Trade accounts payable	(42,518)	[1]	(44,636)
Other accrued liabilities and payables (including taxes)	(106,396)	[1]	(81,407)
Net cash provided by operating activities from continuing operations	46,396	[1]	74,692
Cash flows from investing activities of continuing operations
Purchase of fixed assets	(5,422)	[1]	(3,226)
Purchase of intangibles (licenses)	(693)	[1]	0
Purchase of trademarks	(17,473)	[1]	(6,000)
Acquisitions of subsidiaries, net of cash acquired	(24,125)	[1]	(135,964)
Net cash provided by / (used in) investing activities from continuing operations	(47,713)	[1]	460,389
Cash flows from financing activities of continuing operations
Borrowings on bank loans and overdraft facility	36,027	[1]	18,568
Payment of bank loans, overdraft facility and other borrowings	(37,892)	[1]	(76,265)
Decrease in short term capital leases payable	(34)	[1]	0
Options exercised	72	[1]	2,336
Net cash used in financing activities from continuing operations	(1,827)	[1]	(415,491)
Currency effect on brought forward cash balances	(7,781)	[1]	(13,172)
Net increase / (decrease) in cash	(10,925)	[1]	106,418
Cash and cash equivalents at beginning of period	122,116	[1]	126,439	126,439
Cash and cash equivalents at end of period	111,191	[1]	232,857	122,116	[1]
Supplemental Schedule of Non-cash Investing Activities
Common stock issued in connection with investment in subsidiaries	23,175	[1]	41,344
Supplemental disclosures of cash flow information
Interest paid	50,574	[1]	82,406
Income tax paid	5,770	[1]	25,441
As Reported [Member]
Cash flows from operating activities of continuing operations
Net loss	(835,715)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization	15,328
Deferred income taxes	(3,683)
Unrealized foreign exchange (gains) / losses	118,574
Stock options fair value expense	1,998
Equity (income)/loss in affiliates	8,814
Gain on fair value remeasurement of previously held equity interest	(6,397)
Impairment charge	674,515
Impairments related to assets held for sale	7,355
Other non-cash items	5,899
Changes in operating assets and liabilities:
Accounts receivable	219,475
Inventories	10,860
Prepayments and other current assets	(6,199)
Trade accounts payable	(65,246)
Other accrued liabilities and payables (including taxes)	(99,422)
Net cash provided by operating activities from continuing operations	46,156
Cash flows from investing activities of continuing operations
Purchase of fixed assets	(5,391)
Purchase of intangibles (licenses)	(693)
Purchase of trademarks	(17,473)
Acquisitions of subsidiaries, net of cash acquired	(24,124)
Net cash provided by / (used in) investing activities from continuing operations	(47,681)
Cash flows from financing activities of continuing operations
Borrowings on bank loans and overdraft facility	36,027
Payment of bank loans, overdraft facility and other borrowings	(37,892)
Decrease in short term capital leases payable	(34)
Options exercised	72
Net cash used in financing activities from continuing operations	(1,827)
Currency effect on brought forward cash balances	(7,781)
Net increase / (decrease) in cash	(11,133)
Cash and cash equivalents at beginning of period	122,324
Cash and cash equivalents at end of period	111,191
Supplemental Schedule of Non-cash Investing Activities
Common stock issued in connection with investment in subsidiaries	23,175
Supplemental disclosures of cash flow information
Interest paid	50,574
Income tax paid	5,770
Adjustment [Member]
Cash flows from operating activities of continuing operations
Net loss	(18,387)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization	0
Deferred income taxes	(1,455)
Unrealized foreign exchange (gains) / losses	(208)
Stock options fair value expense	0
Equity (income)/loss in affiliates	(868)
Gain on fair value remeasurement of previously held equity interest	0
Impairment charge	0
Impairments related to assets held for sale	0
Other non-cash items	271
Changes in operating assets and liabilities:
Accounts receivable	26,678
Inventories	(20,043)
Prepayments and other current assets	(1,502)
Trade accounts payable	22,728
Other accrued liabilities and payables (including taxes)	(6,974)
Net cash provided by operating activities from continuing operations	240
Cash flows from investing activities of continuing operations
Purchase of fixed assets	(31)
Purchase of intangibles (licenses)	0
Purchase of trademarks	0
Acquisitions of subsidiaries, net of cash acquired	(1)
Net cash provided by / (used in) investing activities from continuing operations	(32)
Cash flows from financing activities of continuing operations
Borrowings on bank loans and overdraft facility	0
Payment of bank loans, overdraft facility and other borrowings	0
Decrease in short term capital leases payable	0
Options exercised	0
Net cash used in financing activities from continuing operations	0
Currency effect on brought forward cash balances	0
Net increase / (decrease) in cash	208
Cash and cash equivalents at beginning of period	(208)
Cash and cash equivalents at end of period	0
Supplemental Schedule of Non-cash Investing Activities
Common stock issued in connection with investment in subsidiaries	0
Supplemental disclosures of cash flow information
Interest paid	0
Income tax paid	0
Restated [Member]
Cash flows from operating activities of continuing operations
Net loss	(854,102)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization	15,328
Deferred income taxes	(5,138)
Unrealized foreign exchange (gains) / losses	118,366
Stock options fair value expense	1,998
Equity (income)/loss in affiliates	7,946
Gain on fair value remeasurement of previously held equity interest	(6,397)
Impairment charge	674,515
Impairments related to assets held for sale	7,355
Other non-cash items	6,170
Changes in operating assets and liabilities:
Accounts receivable	246,153
Inventories	(9,183)
Prepayments and other current assets	(7,701)
Trade accounts payable	(42,518)
Other accrued liabilities and payables (including taxes)	(106,396)
Net cash provided by operating activities from continuing operations	46,396
Cash flows from investing activities of continuing operations
Purchase of fixed assets	(5,422)
Purchase of intangibles (licenses)	(693)
Purchase of trademarks	(17,473)
Acquisitions of subsidiaries, net of cash acquired	(24,125)
Net cash provided by / (used in) investing activities from continuing operations	(47,713)
Cash flows from financing activities of continuing operations
Borrowings on bank loans and overdraft facility	36,027
Payment of bank loans, overdraft facility and other borrowings	(37,892)
Decrease in short term capital leases payable	(34)
Options exercised	72
Net cash used in financing activities from continuing operations	(1,827)
Currency effect on brought forward cash balances	(7,781)
Net increase / (decrease) in cash	(10,925)
Cash and cash equivalents at beginning of period	122,116
Cash and cash equivalents at end of period	111,191
Supplemental Schedule of Non-cash Investing Activities
Common stock issued in connection with investment in subsidiaries	23,175
Supplemental disclosures of cash flow information
Interest paid	50,574
Income tax paid	$ 5,770

[1] Restated